Medical Journals

Protection of Adult Rat Cardiac Myocytes from Ischemic Cell Death: Role of Caveolar Microdomains and Delta-opioid Receptors.

Authors:
  • Patel Hemal H
  • Head Brian P
  • Petersen Heidi N
  • Niesman Ingrid R
  • Huang Diane
  • Gross Garrett J
  • Insel Paul A
  • Roth David M

From: Department of Pharmacology, University of California, San Diego, VA San Diego Healthcare System, San Diego, CA 92161-5085, USA. hepatel@ucsd.edu

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Jul 2006
  • ISSN: 0363-6135
  • Volume: 291
  • Issue: 1
  • Pages: H344-50
  • Medium: Print
  • Language: English
  • Citation (JAMA): Patel Hemal H, Head Brian P, Petersen Heidi N, et al. Protection of Adult Rat Cardiac Myocytes from Ischemic Cell Death: Role of Caveolar Microdomains and Delta-opioid Receptors.. Am. J. Physiol. Heart Circ. Physiol. Jul 2006;291:H344-50

Abstract

The role of caveolae, membrane microenvironments enriched in signaling molecules, in myocardial ischemia is poorly defined. In the current study, we used cardiac myocytes prepared from adult rats to test the hypothesis that opioid receptors (OR), which are capable of producing cardiac protection in vivo, promote cardiac protection in cardiac myocytes in a caveolae-dependent manner. We determined protein expression and localization of delta-OR (DOR) using coimmunohistochemistry, caveolar fractionation, and immunoprecipitations. DOR colocalized in fractions with caveolin-3 (Cav-3), a structural component of caveolae in muscle cells, and could be immunoprecipitated by a Cav-3 antibody. Immunohistochemistry confirmed plasma membrane colocalization of DOR with Cav-3. Cardiac myocytes were subjected to simulated ischemia (2 h) or an ischemic preconditioning (IPC) protocol (10 min ischemia, 30 min recovery, 2 h ischemia) in the presence and absence of methyl-beta-cyclodextrin (MbetaCD, 2 mM), which binds cholesterol and disrupts caveolae. We also assessed the cardiac protective effects of SNC-121 (SNC), a selective DOR agonist, on cardiac myocytes with or without MbetaCD and MbetaCD preloaded with cholesterol. Ischemia, simulated by mineral oil layering to inhibit gas exchange, promoted cardiac myocyte cell death (trypan blue staining), a response blunted by SNC (37 +/- 3 vs. 59 +/- 3% dead cells in the presence and absence of 1 muM SNC, respectively, P < 0.01) or by use of the IPC protocol (35 +/- 4 vs. 62 +/- 3% dead cells, P < 0.01). MbetaCD treatment, which disrupted caveolae (as detected by electron microscopy), fully attenuated the protective effects of IPC or SNC, resulting in cell death comparable to that of the ischemic group. By contrast, SNC-induced protection was not abrogated in cells incubated with cholesterol-saturated MbetaCD, which maintained caveolae structure and function. These findings suggest a key role for caveolae, perhaps through enrichment of signaling molecules, in contributing to protection of cardiac myocytes from ischemic damage.

Mesh Headings (Keywords): Animals, Caveolae, Cells, Cultured, Myocardial Ischemia, Myocytes, Cardiac, Rats, Rats, Sprague-Dawley, Receptors, Opioid, delta


Check for Full Text / PubMed Unique Identifier (PMID): 16501018


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.